Vanguard Personalized Indexing Management, LLC Biogen Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$6.09 Billion
Q3 2024

A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 11,299 shares of BIIB stock, worth $1.78 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,299

Previous 13,261 14.8%

Holding current value

$1.78 Million

Previous $3.07 Million 28.76%

% of portfolio

0.04%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$189.07 - $236.8 $370,955 - $464,601	-1,962 Reduced 14.8%	11,299 $2.19 Million
Q2 2024 Aug 12, 2024	BUY	$190.52 - $236.72 $543,934 - $675,835	2,855 Added 27.44%	13,261 $3.07 Million
Q1 2024 May 09, 2024	BUY	$212.02 - $267.71 $42,404 - $53,541	200 Added 1.96%	10,406 $2.24 Million
Q4 2023 Feb 07, 2024	SELL	$222.59 - $267.94 $116,859 - $140,668	-525 Reduced 4.89%	10,206 $2.64 Million
Q3 2023 Nov 08, 2023	SELL	$253.3 - $285.89 $156,792 - $176,965	-619 Reduced 5.45%	10,731 $2.76 Million
Q2 2023 Jul 28, 2023	BUY	$275.25 - $318.06 $340,209 - $393,122	1,236 Added 12.22%	11,350 $3.23 Million
Q1 2023 May 10, 2023	BUY	$256.56 - $292.34 $233,213 - $265,737	909 Added 9.88%	10,114 $2.81 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $489,228 - $594,423	1,938 Added 26.67%	9,205 $2.55 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $270,424 - $372,890	1,389 Added 23.63%	7,267 $1.94 Million
Q2 2022 Aug 09, 2022	BUY	$187.54 - $223.02 $507,108 - $603,046	2,704 Added 85.19%	5,878 $1.2 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $198,032 - $249,511	1,022 Added 47.49%	3,174 $668,000
Q4 2021 Feb 23, 2022	SELL	$223.92 - $287.77 $183,838 - $236,259	-821 Reduced 27.62%	2,152 $516,000
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $95,933 - $125,107	339 Added 12.87%	2,973 $841,000
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $313,908 - $502,628	1,212 Added 85.23%	2,634 $912,000
Q1 2021 Apr 28, 2021	BUY	$242.95 - $284.63 $58,065 - $68,026	239 Added 20.2%	1,422 $398,000
Q4 2020 Jan 20, 2021	BUY	$236.26 - $355.63 $279,495 - $420,710	1,183 New	1,183 $290,000
Q4 2020 Jan 19, 2021	SELL	$236.26 - $355.63 $246,182 - $370,566	-1,042 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$264.77 - $305.71 $49,776 - $57,473	188 Added 22.01%	1,042 $296,000
Q2 2020 Jul 27, 2020	SELL	$258.66 - $342.55 $89,237 - $118,179	-345 Reduced 28.77%	854 $228,000
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $322,351 - $408,906	1,199 New	1,199 $379,000

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account

Vanguard Personalized Indexing Management, LLC Biogen Inc. Transaction History